Zobrazeno 1 - 10
of 206
pro vyhledávání: '"Ronald B Goldberg"'
Autor:
Samuel Dagogo-Jack, Carlos Lorenzo, Kieren J Mather, Marinella Temprosa, Tibor V Varga, Jinxi Liu, Ronald B Goldberg, Guannan Chen, Xavier Pi-Sunyer
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction Although various lipid and non-lipid analytes measured by nuclear magnetic resonance (NMR) spectroscopy have been associated with type 2 diabetes, a structured comparison of the ability of NMR-derived biomarkers and standard lipids to pr
Externí odkaz:
https://doaj.org/article/6e1d050c124d4a529a5724c96d670a0f
Autor:
Ronald B Goldberg
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol 2009, Iss default, Pp 11-21 (2009)
Ronald B GoldbergDivision of Endocrinology, Diabetes and Metabolism, Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USAAbstract: Bile sequestrants have been used for almost 50 years to lower low density lipopro
Externí odkaz:
https://doaj.org/article/0d5d94d5830a49bf805e8e05cf3fe83a
Autor:
Toni I Pollin, Tamara Isakova, Kathleen A Jablonski, Paul I W de Bakker, Andrew Taylor, Jarred McAteer, Qing Pan, Edward S Horton, Linda M Delahanty, David Altshuler, Alan R Shuldiner, Ronald B Goldberg, Jose C Florez, Paul W Franks, Diabetes Prevention Program Research Group
Publikováno v:
PLoS Genetics, Vol 8, Iss 8, p e1002895 (2012)
Weight-loss interventions generally improve lipid profiles and reduce cardiovascular disease risk, but effects are variable and may depend on genetic factors. We performed a genetic association analysis of data from 2,993 participants in the Diabetes
Externí odkaz:
https://doaj.org/article/1511d67fc92e4fdfa24084c24f50a268
Autor:
Justin B. Echouffo‐Tcheugui, Sui Zhang, Roberta Florido, James S. Pankow, Erin D. Michos, Ronald B. Goldberg, Vijay Nambi, Gary Gerstenblith, Wendy S. Post, Roger S. Blumenthal, Christie M. Ballantyne, Josef Coresh, Elizabeth Selvin, Chiadi E. Ndumele
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 6 (2024)
Background It is unclear how metabolic syndrome (MetS) and diabetes affect Gal‐3 (galectin 3) levels and the resulting implications for heart failure (HF) risk. We assessed relationships of MetS and diabetes with Gal‐3, and their joint associatio
Externí odkaz:
https://doaj.org/article/2ae882273ed64fc8ac591dde05d50866
Autor:
Ronald B. Goldberg
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 51:603-624
Autor:
Daniel J. Pelchovitz, Haris Subacius, Mark E. Molitch, Jeffrey J. Goldberger, Jason Ng, Smriti Banthia, Alexandru B. Chicos, Ronald B. Goldberg
Publikováno v:
Cardiology Journal. 29:272-283
Background: Cardiac autonomic neuropathy (CAN) is a complication of diabetes mellitus (DM) that is associated with increased mortality. Exercise-based assessment of autonomic function has identified diminished parasympathetic reactivation after exerc
Autor:
Gary Gerstenblith, Wendy S. Post, Roger S. Blumenthal, Erin D. Michos, Carine E. Hamo, James S. Pankow, Elizabeth Selvin, Christie M. Ballantyne, Ronald B. Goldberg, Vijay Nambi, Justin B. Echouffo-Tcheugui, Roberta Florido, Josef Coresh, Sui Zhang, Chiadi E Ndumele
Publikováno v:
JACC: Heart Failure. 9:594-603
Objectives This study assessed the association of diabetes duration with incident heart failure (HF). Background Diabetes increases HF risk. However, the independent effect of diabetes duration on incident HF is unknown. Methods We included 9,734 par
Publikováno v:
Diabetes Care
Daniel H. Mintz Fig. 1 was born in Far Rockaway, New York, in 1930 to European Jewish parents, Jacob and Fanny, and grew up on Long Island, New York, where his parents immigrated in the early 1900s. In his youth he excelled both in sports (basketball
Autor:
Ronald B, Goldberg
Publikováno v:
Endocrinology and metabolism clinics of North America. 51(3)
Elevated triglyceride and reduced high-density lipoprotein cholesterol (HDL-C) are common in type 2 diabetes, but increased atherogenic particles and dysfunctional HDL are demonstrable in both types 1 and 2 diabetes, contributing to a two-fold increa
Autor:
the Diabetes Prevention Program Research Group, David M. Nathan, Mathias Schlögl, Christine Darwin, Xavier Pi-Sunyer, Ronald B. Goldberg, Barbara Blodi, Emily Y. Chew, Dana Dabelea, Emily B. Schroeder, William C. Knowler, Qing Pan, Neil H. White
OBJECTIVE: To determine whether interventions that slow or prevent the development of type 2 diabetes mellitus in those at risk reduce the subsequent prevalence of diabetic retinopathy. RESEARCH DESIGN AND METHODS: The Diabetes Prevention Program (DP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::442d9fcc99adfdcc7eb5661ba1c80819
https://doi.org/10.2337/figshare.19638765
https://doi.org/10.2337/figshare.19638765